Abstract:Objective To study the correlation of galectin-3 level in bronchoalveolar lavage fluid (BALF) with Mycoplasma pneumoniae (MP) load and cellular immunity of neutrophils and macrophages in the airway in children with refractory MP pneumonia (RMPP). Methods A total of 64 children with RMPP who were hospitalized from January 2013 to January 2017 were enrolled. In addition to the conservative medical treatment, all the 64 children with RMPP were given bronchoalveolar lavage in the acute stage (5-7 days after admission) and 48 out of the 64 children were given bronchoalveolar lavage in the recovery stage (10-14 days after admission). Four milliliters of BALF of the affected lung lobe or segment were collected. ELISA was used to measure the level of galectin-3 in BALF supernatant. RT-PCR was used to measure MP load. Hematoxylin and eosin staining was used to measure the percentage of neutrophils and macrophages. Six children with bronchial foreign bodies were enrolled as the control group. Results The RMPP group had a significantly higher level of galectin-3 in BALF in both the acute and recovery stages than the control group (P < 0.01), and the level of galectin-3 in the acute stage was significantly higher than in the recovery stage (P < 0.01). The RMPP group had a significantly higher percentage of neutrophils in BALF in both the acute and recovery stages than the control group (P < 0.01), and the percentage of neutrophils in the acute stage was significantly higher than in the recovery stage (P < 0.01). The RMPP group had a significantly lower percentage of macrophages in BALF in both the acute and recovery stages than the control group (P < 0.01), but there was no significant difference in the percentage of macrophages between the acute and recovery stages (P > 0.05). The RMPP group had a significantly higher MP load in BALF in both the acute and recovery stages than the control group (P < 0.01), and the MP load in the acute stage was significantly higher than in the recovery stage (P < 0.01). In the children with RMPP, galectin-3 level in BALF in the acute stage was positively correlated with MP load and the percentage of neutrophils (rs=0.789 and 0.726 respectively; P < 0.01). Conclusions Galectin-3 is involved in the process of airway inflammation in children with RMPP, and the level of galectin-3 in BALF is positively correlated with MP load. RMPP is a cellular immune inflammatory lesion with the increase of neutrophils and the reduction in macrophages. Galectin-3 is closely associated with neutrophil chemotaxis and luminal infiltration in children with RMPP. MP load gradually decreases with the recovery from RMPP, but it is not completely eliminated by the immune system in the recovery stage. MP infection can increase the consumption of macrophages in children with RMPP.
ZHAO Qian-Ye,SHI Su-Jie,SUN Da-Quan et al. Correlation between galectin-3 level in bronchoalveolar lavage fluid and cellular immunity in children with refractory Mycoplasma pneumoniae pneumonia[J]. CJCP, 2019, 21(2): 150-154.
Liu Y, Zhang X, Wang Y, et al. The role of granulocyte macrophage colony stimulating factor in hospitalized children with Mycoplasma pneumoniae pneumonia[J]. J Infect Chemother, 2018, 24(10):789-794.
Nieminen J, St-Pierre C, Sato S. Galectin-3 interacts with naive and primed neutrophils, inducing innate immune responses[J]. J Leukoc Biol, 2005, 78(5):1127-1135.
[6]
Quenum Zangbede FO, Chauhan A, Sharma J, et al. Galectin-3 in M2 macrophages plays a protective role in resolution of neuropathology in brain parasitic infection by regulating neutrophil turnover[J]. J Neurosci, 2018, 38(30):6737-6750.
[7]
de Oliveira FL, Gatto M, Bassi N, et al. Galectin-3 in autoimmunity and autoimmune diseases[J]. Exp Biol Med (Maywood), 2015, 240(8):1019-1028.
[8]
Saraya T, Watanabe T, Tsukahara Y, et al. The correlation between chest X-ray scores and the clinical findings in children and adults with Mycoplasma pneumoniae pneumonia[J]. Intern Med, 2017, 56(21):2845-2849.
[9]
Wang M, Wang Y, Yan Y, et al. Clinical and laboratory profiles of refractory Mycoplasma pneumoniae pneumonia in children[J]. Int J Infect Dis, 2014, 29:18-23.
[10]
Nieminen J, St-Pierre C, Bhaumik P, et al. Role of galectin-3 in leukocyte recruitment in a murine model of lung infection by Streptococcus pneumoniae[J]. J Immunol, 2008, 180(4):2466-2473.
[11]
Farnworth SL, Henderson NC, Mackinnon AC, et al. Galectin-3 reduces the severity of pneumococcal pneumonia by augmenting neutrophil function[J]. Am J Pathol, 2008, 172(2):395-405.
[12]
Lai JF, Zindl CL, Duffy LB, et al. Critical role of macrophages and their activation via MyD88-NFκB signaling in lung innate immunity to Mycoplasma pneumoniae[J]. PLoS One, 2010, 5(12):e14417.
[13]
Maldonado CA, Sundblad V, Salatino M, et al. Cell-type specific regulation of galectin-3 expression by glucocorticoids in lung Clara cells and macrophages[J]. Histol Histopathol, 2011, 26(6):747-759.
[14]
Ginhoux F, Jung S. Monocytes and macrophages:developmental pathway and tissue homeostasis[J]. Nat Rev Immunol, 2014, 14(6):392-404.